1. Catalogs
  2. Masimo
  3. Eve™ CCHD
video corpo

Eve™ CCHD

Eve™  CCHD

Eve™ CCHD

Product catalog summary
Overview: The Eve™ CCHD Newborn Screening Application integrates Masimo SET® pulse oximetry technology to assist clinicians in screening for Critical Congenital Heart Disease (CCHD). It provides step-by-step instructions, visual aids, and an automatic synchronization algorithm to enhance the screening process.
Key Features:
  • Visual and Animated Guidance: The application offers visual instructions and animations to guide clinicians through the screening process, improving consistency and workflow efficiency.
  • Automatic Synchronization Algorithm: This feature helps reduce calculation errors by providing an easy-to-interpret results screen.
  • Perfusion Index (Pi) Measurement: Settings allow for the incorporation of Pi measurement, potentially increasing the sensitivity of CCHD detection.
  • EMR Integration: Integration with Masimo Patient SafetyNet™ or Iris Gateway™ facilitates workflow and may reduce reporting errors.
Device Compatibility: The Eve application is available on the Rad-97™ and Radical-7® Pulse CO-Oximeters®.
Clinical Efficacy:
  • Studies have shown that the use of Masimo SET® pulse oximetry increases CCHD screening sensitivity significantly when combined with physical exams and clinical assessments.
  • In a study of 39,821 infants, sensitivity increased from 63% with physical exam alone to 83% with the addition of Masimo SET® pulse oximetry.
  • In a larger study of 122,738 infants, sensitivity increased from 77% to 93% with the combined use of Masimo SET® and clinical assessment.
Regulatory Information: Eve has obtained CE Marking and is not available in the U.S. The Rad-97 with Eve is not licensed for sale in Canada.
Contact Information: For more details, contact Masimo International or Masimo U.S. through the provided phone numbers and email addresses.
See more

Catalog excerpts

Eve™  CCHD-1

Eve CCHD Newborn Screening Application ™ Eve combines Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry with step-by-step instructions to assist clinicians in screening for Critical Congenital Heart Disease (CCHD) Eve application is available on the Rad-97™ and Radical-7® Pulse CO-Oximeters® Eve simplifies the CCHD screening process, per an established protocol1, by providing visual instructions, animations, an automatic synchronization algorithm, and a detailed, easy-to-interpret display of screening results Animations provide visual guidance to assist clinicians through the screening process An automatic synchronization algorithm, with an easy-tointerpret results screen, may reduce calculation errors Settings allow clinicians to incorporate perfusion index (Pi) measurement, which may increase sensitivity to detection of CCHD2 EMR integration via Masimo Patient SafetyNet™* or Iris Gateway™ facilitates workflow and may help reduce report

 Open the catalog to page 1
Eve™  CCHD-2

STEP 1: Sensor Placement on Right Hand Animated instructions guide proper site selection Real-time display of measurement data, pleth waveform, and changes in signal quality © 2018 Masimo. All rights reserved. Step-By-Step Instruction Improves Consistency and Workflow Efficiency STEP 2: Sensor Placement on Either Foot STEP 3: Two Possible Screening Results CCHD Screening with Masimo SET® Pulse Oximetry >> In a study of 39,821 infants, CCHD screening sensitivity increased from 63% with physical exam alone to 83% with physical exam and Masimo SET® pulse oximetry.2 >> In a study of 122,738 infants,...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.